302 related articles for article (PubMed ID: 4189147)
21. [Continuous administration of a low dosage progestational agent (Mini Pill)].
Schmitt R; Fettig O; Hepp H
Geburtshilfe Frauenheilkd; 1972 Mar; 32(3):214-20. PubMed ID: 4112660
[No Abstract] [Full Text] [Related]
22. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
[No Abstract] [Full Text] [Related]
23. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
[No Abstract] [Full Text] [Related]
24. [Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
Böhme HH; Otto HJ
Zentralbl Gynakol; 1985; 107(5):311-2. PubMed ID: 2581395
[TBL] [Abstract][Full Text] [Related]
25. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive.
Christie GA
Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973
[No Abstract] [Full Text] [Related]
26. [Nonanouvlatory doses of sequential mestranol-chlormadinone combination in female acne].
Romiti N
An Bras Dermatol; 1971; 46(1):13-8. PubMed ID: 4108151
[No Abstract] [Full Text] [Related]
27. [Menstruation and endometrium after hormonal contraception].
Böhm W; Klinger G; Hempel E
Zentralbl Gynakol; 1972 Jul; 94(30):945-51. PubMed ID: 4118151
[No Abstract] [Full Text] [Related]
28. [Experience with Ovosiston for contraception. II].
Geschke H
Dtsch Gesundheitsw; 1970 Feb; 25(5):201-6. PubMed ID: 4192921
[No Abstract] [Full Text] [Related]
29. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
Matthews AE; Clarke JE
J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
[No Abstract] [Full Text] [Related]
30. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
Sawasaki C; Ashitaka Y
J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
[No Abstract] [Full Text] [Related]
31. Cytohormonal findings in patients using various forms of contraception.
Reyniak JV; Sedlis A; Stone D; Connell E
Acta Cytol; 1969 Jun; 13(6):315-22. PubMed ID: 4184413
[No Abstract] [Full Text] [Related]
32. [Amenorrhea-galactorrhea following the use of ovosiston].
Kosowski I; Stojanow G; Iliewa W
Zentralbl Gynakol; 1973 Jun; 95(25):851-4. PubMed ID: 4126137
[No Abstract] [Full Text] [Related]
33. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
Rościszewska D
Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
[No Abstract] [Full Text] [Related]
34. Some apparently common problems in patients receiving contraceptive pills.
Ball P
Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
[No Abstract] [Full Text] [Related]
35. [Two-stage therapy as a method of hormonal contraception in comparison with compound preparations].
Rothe K
Z Gesamte Hyg; 1970 Apr; 16(4):289-90. PubMed ID: 4108397
[No Abstract] [Full Text] [Related]
36. Oral contraceptives, hypertension, and toxemia.
Carmichael SM; Taylor MM; Ayers CR
Obstet Gynecol; 1970 Mar; 35(3):371-6. PubMed ID: 4190423
[No Abstract] [Full Text] [Related]
37. [Towards a more physiological hormonal contraception].
Stĕrba R
Zentralbl Gynakol; 1970 Mar; 92(10):303-12. PubMed ID: 4096927
[No Abstract] [Full Text] [Related]
38. [Testing of an anti-conception drug: pure gestagen (chlormadinone acetate) in continually low dose].
Jeppsson S; Kullander S
Lakartidningen; 1969 Sep; 66(39):3949-55. PubMed ID: 4192490
[No Abstract] [Full Text] [Related]
39. [Are oral contraceptives contraindicated after pregnancy hepatosis?].
Rannevik G; Jeppsson S; Kullander S; Laurell CB
Nord Med; 1971 Aug; 86(33):986. PubMed ID: 4106201
[No Abstract] [Full Text] [Related]
40. [Comparison of changes in erythrocyte and resin tests induced by the use of Femigen-forte and Femifen (Polfa) preparations as contraceptives].
Pisarek-Miedzińska D; Czech W; Firek A
Ginekol Pol; 1974 Jan; 45(1):57-60. PubMed ID: 4131322
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
